Skip to content

Prostate Bipolar Enucleation and Resection Versus Open Prostatectomy

Transurethral Bipolar Enucleation and Resection of the Prostate Versus Open Prostatectomy for the Treatment of Benign Prostatic Hyperplasia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05416606
Enrollment
64
Registered
2022-06-13
Start date
2020-10-01
Completion date
2022-06-01
Last updated
2022-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Keywords

Transurethral enucleation, Transurethral enucleation and resection of the prostate, plasma enucleation, prostate enucleation, Open Prostatectomy, BPH, Benign prostatic hyperplasia

Brief summary

Benign prostatic hyperplasia (BPH) is a frequent disease in aging men accompanied by bladder outlet obstruction (BOO). Open prostatectomy (OP) is still considered the first-line treatment for more than 80 ml prostate size. In this study, a mixed technique called transurethral bipolar enucleation and resection of the prostate (TBERP) was compared to the standard open prostatectomy.

Detailed description

Benign prostatic hyperplasia (BPH) is a frequent disease in aging men accompanied by bladder outlet obstruction (BOO). Open prostatectomy (OP) is still considered the first-line treatment for more than 80 ml prostate size. In this study, a mixed technique called transurethral bipolar enucleation and resection of the prostate (TBERP) was compared to the standard open prostatectomy. This is a Comparative, Prospective Study conducted on men over 50 years.The patients were randomly distributed into two groups treated by TBERP and OP. Patients were evaluated preoperatively and at 1-week post catheter removal and 1-3-months postoperatively in terms of blood loss, operation time, the weight of resected prostatic tissues, post-operative catheterisation period, hospital stay, IPSS, PVR, prostate volume, early complications (recatheterization, urine retention, UTI and irritative symptoms) and late complications (urinary incontinence, urethral stricture and bladder neck contracture).

Interventions

PROCEDUREtransurethral bipolar enucleation and resection of the prostate

transurethral bipolar enucleation and resection of the prostate

PROCEDUREopen surgical transvesical prostatectomy

open surgical transvesical prostatectomy

Sponsors

Helwan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

In this study, a hybrid technique, that combines two types of techniques using the same cutting current and technological setup, will be proposed enucleation of the prostate gland with the plasma vaporization electrode and resection with a TURis cutting loop. This technique is defined as transurethral vapor enucleation and resection of the prostate (TVERP) comparing it with open prostatectomy.

Eligibility

Sex/Gender
MALE
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male patients * Age more than 50 years * Prostate size of more than 80 ml * IPSS ≥ 8, and maximum urinary flow rate (Qmax) ≤ 15 mL/s * Indications for surgery * Refractory retention (failed ≥1 trial of voiding). * Associated bladder Stones. * Associated recurrent gross Hematuria. * Associated with recurrent Infections. * Associated renal insufficiency. * Bother symptoms refractory to medical treatment.

Exclusion criteria

* Uncorrectable coagulopathy. * Patient with active UTI. * Prostate less than 80 ml. * Severe associated comorbidities. * Previous urethral, prostate, and bladder surgeries, * Patients diagnosed with neurogenic bladder. * Patients diagnosed with prostate cancer.

Design outcomes

Primary

MeasureTime frameDescription
operative timeThree monthsTo measure the difference between the two procedure regarding operative time measured in minutes.
recovery outcomeThree monthsTo measure the difference between the two procedure regarding mean hospital stays measured in days and catheterization period measured in days

Secondary

MeasureTime frameDescription
peri-operative complicationThree monthsto measure the difference between the two procedures regarding incidence of early complications including re-catheterization, acute urinary retention, early irritative symptoms and urinary tract infections and incidence of late complications Including urinary incontinence, Urethral strictures,and bladder neck contracture.
weight of resected prostatic tissuesThree monthsto measure the difference between the two procedures regarding weight of resected prostatic tissues Measured in gram
post-operative International Prostate Symptom Score (IPSS) score.Three monthsto measure the difference between the two procedures regarding IPSS score. Score 0 to 7 points considered mild symptoms, 8 to 19 points considered moderate symptoms, 20 to 35 points considered severe symptoms

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026